Podcast Episodes
Back to Search
Kudla on Commodities, Defense, and Market Upside
David Kudla says markets may be setting up for a rally as fundamentals diverge from geopolitical headlines. He discusses rising earnings expectations…
1 month ago
Technical Tuesday: SPX, GS & NEE
Kevin Horner says the S&P 500’s (SPX) relief rally still faces key technical resistance, with the 20‑day and 200‑day moving averages in focus. He hig…
1 month ago
Audrey Symes on AI, Jobs, and Career Adaptability
Audrey Symes explains how AI is reshaping entry‑level careers, turning routine tasks into automated workflows and giving digital‑native workers an ed…
1 month ago
Ca$htag$: NKE Steps Down as Earnings Loom
Nike (NKE) heads into earnings near nine‑year lows as its push into direct‑to‑consumer sales backfires and competitors gain shelf space. LikeFolio's …
1 month ago
JOLTS Signals a Low‑Hire, Low‑Fire Labor Market
Jordan Shapiro and Noah Yosif break down the latest JOLTS report, highlighting a “low hire, low fire” labor market as employers and workers turn caut…
1 month ago
'Bull is Sleeping, Not Dead:' Economic 'Coiled Spring' to Relaunch Bull Run
Despite inflation fears, U.S.-Iran uncertainty, and private credit concerns mounting a bearish narrative, Samuel Diarbakerly says "the bull is sleepi…
1 month ago
Progress Software CEO on Earnings & Monetizing the AI Shift
Progress Software (PRGS) beat earnings expectation, though the stock still sold off following the report. CEO Yogesh Gupta explains how the company i…
1 month ago
The Big 3: VST, C, AAPL
Jessica Inskip returns to the Big 3 by offering insight on stocks she expects to show resilience against the current geopolitical volatility. She poi…
1 month ago
Nike's (NKE) Turnaround Story Faces New Test into Earnings
Nike (NKE) heads into earnings near multi‑year lows as product pressure and heavy discounting weigh on the brand in CEO Elliott Hill's company turnar…
1 month ago
NVO Stock "Nothing Short of Disaster," Wegovy Subscription Program Lifts Shares
Novo Nordisk (NVO) shares continued to sink deeper into five-year lows on Monday as developments from Eli Lilly (LLY) outshine the Danish GLP-1 maker…
1 month ago